Gutry Phil
SEC CIK 1653224 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Chief BUSINESS Off | 299.9K | $20.1K | — | 3 | 2021-01-15 | 2022-04-11 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Gutry Phil made no open-market trades at LENZ in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2022-04-11 | LENZ | LENZ Therapeutics, Inc. | Gutry Phil | Chief BUSINESS Off | P - Purchase | $4.01 | +5,000 | 299.9K | +2% | +$20.1K | |
| DM | 2021-07-01 | 2021-01-15+ | LENZ | LENZ Therapeutics, Inc. | Gutry Phil | Chief BUSINESS Off | M - OptEx | $0.5074 | +94.8K | 282.0K | +51% | +$48.1K |
| D | 2021-07-01 | 2021-06-29 | LENZ | LENZ Therapeutics, Inc. | Gutry Phil | Chief BUSINESS Off | C - Cnv Deriv | — | +8,126 | 293.5K | +3% | — |
Purchase Sale Sale after option exercise All abbreviations